CD8A and chronic myelogenous leukemia, BCR-ABL1 positive: To determine if sBC are able to be targeted by CD8+ T cells in an antigen specific manner, a cell mediated lymphocytocixity (CML) assay was run with dispersed clusters of sBC differentiated from 1-023, 2395, or 1-018 as targets.